|
HY-N10898-1mg
|
MedChemexpress LLC
|
(-)-Dihydroguaiaretic acid [CAS 124649-78-1]
|
|
|
|
|
HY-126042-10mg
|
MedChemexpress LLC
|
(�)-Lisofylline [CAS 6493-06-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-126042-100mg
|
MedChemexpress LLC
|
(�)-Lisofylline [CAS 6493-06-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-126042-5mg
|
MedChemexpress LLC
|
(�)-Lisofylline [CAS 6493-06-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-126042-50mg
|
MedChemexpress LLC
|
(�)-Lisofylline [CAS 6493-06-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-1mL
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-10mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-100mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-25mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-5mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12515C-50mg
|
MedChemexpress LLC
|
(R)-Nicardipine [CAS 76093-35-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N6937-10mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-20mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-5mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-1mL
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-66011B-1mg
|
MedChemexpress LLC
|
(Rac)-Moxifloxacin [CAS 354812-41-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-120973A-500ug
|
MedChemexpress LLC
|
(S)-Butaprost (free acid) [CAS 433219-55-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-12940A-10mg
|
MedChemexpress LLC
|
(S)-GLPG0974 [CAS 2326220-69-1]
|
|
|
|
|
HY-12940A-25mg
|
MedChemexpress LLC
|
(S)-GLPG0974 [CAS 2326220-69-1]
|
|
|
|
|
HY-12940A-5mg
|
MedChemexpress LLC
|
(S)-GLPG0974 [CAS 2326220-69-1]
|
|
|
|
|
HY-12515B-10mg
|
MedChemexpress LLC
|
(S)-Nicardipine [CAS 76093-36-2]
|
|
Neuroscience-Neuromodulation
|
|
